India to Hong Kong: Hydroxychloroquine Export Trade Route

The India to Hong Kong Hydroxychloroquine corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $521.2K USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's hydroxychloroquine manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $130.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with hydroxychloroquine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 22.2%, placing it at rank #13 among India's top hydroxychloroquine export destinations globally.

On the import side, key buyers of Indian hydroxychloroquine in Hong Kong include CHEMILL PHARMA LTD, CHEMILL PHARMA LTD , CHEMILL PHARMA LIMITED. CHEMILL PHARMA LTD is the single largest importer with 2 shipments valued at $255.2K USD.

India's hydroxychloroquine exports to Hong Kong are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Hong Kong benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, ZYDUS LIFESCIENCES LIMITED , CADILA HEALTHCARE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $130.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as hydroxychloroquine sulfate tablet usp 200mg hydroxychloroquine sulfate tablet usp 200mg 1 x 500 t and pharma medicine for human use-hydroxychloroquine sulfate tablets usp 200mg 1 x500 t quantity 6055.000 as per invoice, suggesting that buyers in Hong Kong tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CHEMILL PHARMA LTD is the largest importer with 2 shipments worth $255.2K USD — representing 49% of all hydroxychloroquine imports from India on this route.